Patent · US Active

Migrastatins and uses thereof

US9303009B2 · kind B2 · utility

1Cited by

6References

25Claims

0Family size

Assignee

Sloan Kettering Institute for Cancer Research · US

Inventors

Samuel J. Danishefsky · New Haven, US
Joan Massague · New York, US
Manuel Valiente Cortes · New York, US
Thordur Oskarsson · Vestmannaeyjabær, IS
Malcom Moore · New York, US
Nicolas Lecomte · New York, US
Ouathek Ouerfelli · Fort Lee, US
Guangli Yang · Elmont, US

Key dates

Filing date	Apr 6, 2012
Grant date	Apr 5, 2016
Priority date	—
Expiry date	Apr 6, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.